Movement changes, injury recovery, post-operative support questions, or senior-dog mobility where a veterinarian can review the whole history.
Mobility, connective-tissue and recovery research
PET157 Mobility
BPC-157 + TB-500
Mobility, connective-tissue and recovery research built around BPC-157 and TB-500 pathways.
No payment today. A request is reviewed before any next step.
PET157MobilityBPC-157 + TB-500Research concept
A quick fit check
Is this right for my pet?
The animal needs urgent care, cannot bear weight, is rapidly deteriorating, or the owner is looking for an automatic treatment decision. PET157 is not for emergency care.
Published programme notes are general product information, not instructions for an individual animal. Professional review decides whether any pathway or plan is appropriate.
Package options
Three strengths. One 2 mL pen format.
Choose the package strength during the request. We recommend the S, M or L pen size that corresponds to your canine, while final suitability remains subject to professional review and regional availability. Discount applies to the pen subtotal; shipping is added after review.
Formula identity: The exact peptide and salt combination is a proprietary PET157-held trade secret. Verified batch-specific documentation is released only when it exists and is appropriate for professional review.
Presentation: Reviewed orders are prepared in sealed, tamper-evident packaging with integrity checks, light-protective secondary packaging and temperature-aware dispatch planning where appropriate. Dispatch is from Switzerland.
How ordering works
Three clear steps.
- 01Choose the pen
Select the research concept that best matches the question you want reviewed.
- 02Tell us about your pet
Share the concern, history, medications and region in one short request.
- 03Review before payment
A professional pathway and local availability are checked before any commercial next step.
Research, evidence and limitations
The boundary that matters
Mobility, connective-tissue and recovery research remains a professional-review concept. Controlled canine combination trials have not established clinical efficacy.
A research rationale does not establish a clinical outcome or replace professional review.
Read the full researchPET157 evidence grade
What kind of evidence exists?
These labels describe the evidence category, not a recommendation for treatment.
- Canine clinical evidence
- None identified
- Direct canine efficacy trials
- None identified
- Canine safety / PK data
- Component data only
- Other-animal preclinical data
- Indirect only
- Human investigational data
- Indirect only
- Veterinary approval
- Not approved
Discussion in context
Watch the claim. Then check the evidence.
These independent discussions show what owners are hearing online. PET157 links them as original context and keeps their claims separate from canine clinical evidence.
YouTube Short
Peptide Therapy in Pets - BPC-157!
Dr. Katie Woodley - The Natural Pet Doctor
A brief independent veterinary discussion of BPC-157 in pets.
Independent educational discussion. This is not clinical proof, PET157 endorsement or owner instructions.![Video thumbnail for Peptides for Dogs and Cats: The Missing Signal in Chronic Disease [Holistic Vet Advice]](/assets/images/youtube-pet-peptides.webp)
YouTube video
Peptides for Dogs and Cats: The Missing Signal in Chronic Disease [Holistic Vet Advice]
Dr. Katie Woodley - The Natural Pet Doctor
A longer independent discussion spanning mobility, recovery, skin and digestive questions.
Independent educational discussion. This is not clinical proof, PET157 endorsement or owner instructions.